Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,453,681
+$142,784 QoQ
Shares Held
8,966
-7.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#504
of 1,735 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Machina Capital S.A.S. holds $13,316,412 across 9 Biotechnology names. VRTX ranks #1 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,966 | $4,453,681 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,827 | $2,386,287 | |
| 3 | RPRX |
Royalty Pharma plc
|
30,050 | $1,684,903 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
7,540 | $1,412,091 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
29,460 | $1,042,589 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
54,875 | $799,528 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,335 | $702,905 | |
| 8 | EXEL |
Exelixis, Inc.
|
10,761 | $585,506 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,453,681 | 8,966 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,310,897 | 9,654 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,295,815 | 5,064 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,373,443 | 11,167 | Shares | Sole | 2025-11-05 | |
| 2024-06-30 | $992,280 | 2,117 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $833,511 | 1,994 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $816,493 | 2,348 | Shares | Sole | 2023-11-03 | |
| 2023-03-31 | $283,563 | 900 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $317,658 | 1,100 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||